Analysis | Delay | Mean UVN + placebo | Mean UVN + met | SE of diff | q | DF | p value* |
---|---|---|---|---|---|---|---|
Cellular analyses | |||||||
 IBA1-ir cells | D3 | 46.8 | 8.33 | 5.86 | 9.28 | 67 | < 0.0001*** |
D30 | 36.1 | 13.9 | 7.24 | 4.34 | 67 | 0.0085*** | |
 GFAP-ir cells | D3 | 49.6 | 16.1 | 4.5 | 10.5 | 63 | < 0.0001*** |
D30 | 34.1 | 16 | 6.63 | 3.86 | 63 | 0.0219* | |
 % GR/DAPI ir-cells | D3 | 65.3 | 44.8 | 8.08 | 3.58 | 56 | 0.0373* |
 BrdU-ir cells | D3 | 31.7 | 20.6 | 4.14 | 3.79 | 45 | 0.0271* |
D30 | 29.9 | 2.13 | 3.95 | 9.95 | 45 | < 0.0001*** | |
 KCC2 fluorescence intensity | D3 | 43.8 | 84 | 3.96 | 14.3 | 162 | < 0.0001*** |
Behavioral analyses | |||||||
 Qualitative scale | D3 | 4.88 | 6.35 | 0.565 | 3.7 | 368 | 0.0251* |
D7 | 4 | 5.67 | 0.565 | 4.17 | 368 | 0.0095** | |
D14 | 2.24 | 4.33 | 0.565 | 5.25 | 368 | 0.0007***Â | |
D21 | 1.94 | 3.93 | 0.565 | 4.98 | 368 | 0.0014**Â | |
D30 | 2.06 | 3.47 | 0.565 | 3.52 | 368 | 0.0352* | |
 Support surface | D7 | 1.15 | 1.76 | 0.141 | 6.1 | 174 | < 0.0001*** |
D14 | 1.08 | 1.74 | 0.141 | 6.65 |  174 | < 0.0001*** | |
D21 | 0.957 | 1.62 | 0.141 | 6.63 |  174 | < 0.0001*** | |
D30 | 0.929 | 1.55 | 0.141 | 6.22 |  174 | < 0.0001*** | |
 Left circling | D3 | 1.38 | 7.4 | 1.37 | 6.22 | 51 | 0.0002*** |
D30 | 0.813 | 4.5 | 1.37 | 3.81 | 51 | 0.0255* | |
 Weight distributed on the abdomen | D30 |  − 1.76 | 7.31 | 2.46 | 5.21 | 34 | 0.0022** |
 Evolution of the barycenter inertia | D30 | 1.29 | 3.81 | 0.868 | 4.1 | 38 | 0.0166* |
 Evolution of the barycenter’s lateral maximum deviation | D30 | 1.13 | 1.78 | 0.261 | 3.54 | 38 | 0.0432* |
 Mean body torsion | D1 | 5.56 | 11.5 | 2.1 | 3.97 | 248 | 0.0148* |
D2 | 3.73 | 8.99 | 2.1 | 3.55 | 248 | 0.0340* |